Medical Supply Procurement & Distribution (NDC69618-002)

The contract entails the procurement, packaging, and delivery of up to 10 units of a specified medical item identified by NDC69618-002, which is likely Meclizine Hydrochloride, under an IDIQ delivery order framework that supports potential future orders totaling up to $20 million. The work is being conducted under a subcontract arrangement issued by the Defense Logistics Agency, a component of the Department of Defense, and falls under the NAICS code 424210, which classifies pharmaceutical and biomedical product merchant wholesalers. The solicitation was posted on June 26, 2026, and the performance location is not specified, implying nationwide or multi-site distribution consistent with DLA’s logistics operations. The contract structure allows for flexible ordering over time, ensuring ongoing supply continuity without requiring separate solicitations for each delivery. All activities must adhere to federal medical supply standards and DLA’s stringent packaging and tracking requirements to support military and defense medical readiness.